Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 3595

1.

Sonothrombolysis.

Meairs S.

Front Neurol Neurosci. 2015;36:83-93. doi: 10.1159/000366239. Epub 2014 Dec 22.

PMID:
25531665
[PubMed - in process]
2.

Treatment with recombinant tissue plasminogen activator (r-TPA) induces neutrophil degranulation in vitro via defined pathways.

Carbone F, Vuilleumier N, Bertolotto M, Burger F, Galan K, Roversi G, Tamborino C, Casetta I, Seraceni S, Trentini A, Dallegri F, da Silva AR, Pende A, Artom N, Mach F, Coen M, Fainardi E, Montecucco F.

Vascul Pharmacol. 2014 Dec 18. pii: S1537-1891(14)00206-7. doi: 10.1016/j.vph.2014.11.007. [Epub ahead of print]

PMID:
25530154
[PubMed - as supplied by publisher]
3.

The susceptibility vessel sign at the proximal M1: A strong predictor for poor outcome after intravenous thrombolysis.

Aoki J, Kimura K, Shibazaki K, Saji N, Uemura J, Sakamoto Y, Nagai K.

J Neurol Sci. 2014 Dec 8. pii: S0022-510X(14)00767-9. doi: 10.1016/j.jns.2014.12.002. [Epub ahead of print]

PMID:
25529923
[PubMed - as supplied by publisher]
4.

Renal dysfunction and thrombolytic therapy in patients with acute ischemic stroke: a systematic review and meta-analysis.

Hao Z, Yang C, Liu M, Wu B.

Medicine (Baltimore). 2014 Dec;93(28):e286. doi: 10.1097/MD.0000000000000286.

PMID:
25526464
[PubMed - in process]
5.

Successful Thrombolysis despite Having an Incidental Unruptured Cerebral Aneurysm.

Briosa E Gala D, Almeida A, Monteiro N, Paiva Nunes A, Ferreira P, Mendonça N, Amaral-Silva A, Alcântara J.

Case Rep Neurol Med. 2014;2014:323049. doi: 10.1155/2014/323049. Epub 2014 Nov 24.

PMID:
25525532
[PubMed]
Free PMC Article
6.

A Systemized Stroke Code Significantly Reduced Time Intervals for using Intravenous Tissue Plasminogen Activator under Magnetic Resonance Imaging Screening.

Sohn S, Park H, Cha J, Nah H, Kim D, Kang M, Choi J, Huh J.

J Stroke Cerebrovasc Dis. 2014 Dec 15. pii: S1052-3057(14)00481-9. doi: 10.1016/j.jstrokecerebrovasdis.2014.09.020. [Epub ahead of print]

PMID:
25524016
[PubMed - as supplied by publisher]
7.

Recombinant Tissue-Type Plasminogen Activator Plus Eptifibatide Versus Recombinant Tissue-Type Plasminogen Activator Alone in Acute Ischemic Stroke: Propensity Score-Matched Post Hoc Analysis.

Adeoye O, Sucharew H, Khoury J, Tomsick T, Khatri P, Palesch Y, Schmit PA, Pancioli AM, Broderick JP.

Stroke. 2014 Dec 18. pii: STROKEAHA.114.006743. [Epub ahead of print]

PMID:
25523054
[PubMed - as supplied by publisher]
8.

A Randomized Trial of Intraarterial Treatment for Acute Ischemic Stroke.

Berkhemer OA, Fransen PS, Beumer D, van den Berg LA, Lingsma HF, Yoo AJ, Schonewille WJ, Vos JA, Nederkoorn PJ, Wermer MJ, van Walderveen MA, Staals J, Hofmeijer J, van Oostayen JA, Nijeholt GJ, Boiten J, Brouwer PA, Emmer BJ, de Bruijn SF, van Dijk LC, Kappelle LJ, Lo RH, van Dijk EJ, de Vries J, de Kort PL, van Rooij WJ, van den Berg JS, van Hasselt BA, Aerden LA, Dallinga RJ, Visser MC, Bot JC, Vroomen PC, Eshghi O, Schreuder TH, Heijboer RJ, Keizer K, Tielbeek AV, den Hertog HM, Gerrits DG, van den Berg-Vos RM, Karas GB, Steyerberg EW, Flach HZ, Marquering HA, Sprengers ME, Jenniskens SF, Beenen LF, van den Berg R, Koudstaal PJ, van Zwam WH, Roos YB, van der Lugt A, van Oostenbrugge RJ, Majoie CB, Dippel DW; the MR CLEAN Investigators.

N Engl J Med. 2014 Dec 17. [Epub ahead of print]

PMID:
25517348
[PubMed - as supplied by publisher]
Free Article
9.

Anton-Babinski syndrome in an old patient: a case report and literature review.

Chen JJ, Chang HF, Hsu YC, Chen DL.

Psychogeriatrics. 2014 Dec 16. doi: 10.1111/psyg.12064. [Epub ahead of print]

PMID:
25515048
[PubMed - as supplied by publisher]
10.

Update on intra-arterial thrombolysis in patients with lower limb ischemia.

Acosta S, Kuoppala M.

J Cardiovasc Surg (Torino). 2014 Dec 16. [Epub ahead of print]

PMID:
25512316
[PubMed - as supplied by publisher]
11.

Gaps and Hurdles Deter Against Following Stroke Guidelines for Thrombolytic Therapy in Iran: Exploring the Problem.

Nikkhah K, Avan A, Shoeibi A, Azarpazhooh A, Ghandehari K, Foerch C, Saposnik G, Sasannejad P, Vakili V, Layegh P, Farzadfard MT, Bavarsad Shahripour R, Hosseini MR, Azarpazhooh MR.

J Stroke Cerebrovasc Dis. 2014 Dec 12. pii: S1052-3057(14)00468-6. doi: 10.1016/j.jstrokecerebrovasdis.2014.09.012. [Epub ahead of print]

PMID:
25511616
[PubMed - as supplied by publisher]
12.

Carotid Ultrasonography Can Identify Stroke Patients Ineligible for Intravenous Thrombolysis Therapy due to Acute Aortic Dissection.

Hama Y, Koga M, Tokunaga K, Takizawa H, Miyashita K, Iba Y, Toyoda K.

J Neuroimaging. 2014 Dec 16. doi: 10.1111/jon.12186. [Epub ahead of print]

PMID:
25511609
[PubMed - as supplied by publisher]
13.

Complications of the endovascular management of acute ischemic stroke.

Gill HL, Siracuse JJ, Parrack IK, Huang ZS, Meltzer AJ.

Vasc Health Risk Manag. 2014 Nov 28;10:675-681. eCollection 2014. Review.

PMID:
25506222
[PubMed - as supplied by publisher]
Free PMC Article
14.

Intravenous thrombolysis in a patient with left atrial myxoma with acute ischemic stroke.

Kulkarni GB, Yadav R, Mustare V, Modi S.

Ann Indian Acad Neurol. 2014 Oct;17(4):455-8. doi: 10.4103/0972-2327.144038.

PMID:
25506173
[PubMed]
Free PMC Article
15.

NURR1 Involvement in Recombinant Tissue-Type Plasminogen Activator Treatment Complications After Ischemic Stroke.

Merino-Zamorano C, Hernández-Guillamon M, Jullienne A, Béhot AL, Bardou I, Parés M, Fernández-Cadenas I, Giralt D, Carrera C, Ribó M, Vivien D, Ali C, Rosell A, Montaner J.

Stroke. 2014 Dec 11. pii: STROKEAHA.114.006826. [Epub ahead of print]

PMID:
25503547
[PubMed - as supplied by publisher]
16.

Predictors of Poor Hospital Discharge Outcome in Acute Stroke Due To Atrial Fibrillation.

Tian MJ, Tayal AH, Schlenk EA.

J Neurosci Nurs. 2014 Dec 10. [Epub ahead of print]

PMID:
25503541
[PubMed - as supplied by publisher]
17.

Do Billing Codes Accurately Capture Intravenous Tissue Plasminogen Activator Treatment Rates? Justified Concern for Clinical Performance Measures Based on Billing Code Assignment.

Palazzo P, Alexandrov AV, Alexandrov AW.

J Stroke Cerebrovasc Dis. 2014 Dec 9. pii: S1052-3057(14)00428-5. doi: 10.1016/j.jstrokecerebrovasdis.2014.08.024. [Epub ahead of print]

PMID:
25498735
[PubMed - as supplied by publisher]
18.

Improved door-to-needle times and neurologic outcomes when intravenous tissue plasminogen activator is administered by emergency physicians with advanced neuroscience training.

Greenberg K, Maxwell CR, Moore KD, D'Ambrosio M, Liebman K, Veznedaroglu E, Sanfillippo G, Diaz C, Binning MJ.

Am J Emerg Med. 2014 Nov 28. pii: S0735-6757(14)00860-2. doi: 10.1016/j.ajem.2014.11.025. [Epub ahead of print]

PMID:
25498530
[PubMed - as supplied by publisher]
19.

The potential of 12/15-lipoxygenase inhibitors in stroke therapy.

van Leyen K, Holman TR, Maloney DJ.

Future Med Chem. 2014 Nov;6(17):1853-5. doi: 10.4155/fmc.14.129. No abstract available.

PMID:
25495979
[PubMed - in process]
20.

Robotic Telepresence Versus Standardly Supervised Stroke Alert Team Assessments.

O'Carroll CB, Hentz JG, Aguilar MI, Demaerschalk BM.

Telemed J E Health. 2014 Dec 9. [Epub ahead of print]

PMID:
25490742
[PubMed - as supplied by publisher]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk